Sheri Dodd

Chief Executive Officer at TACTILE SYSTEMS TECHNOLOGY, INC.

Net worth: 5 M $ as of 30/12/2025

60 year

Consumer Services

Health Technology

Profile

Sheri L.
Dodd currently works at Tactile Systems Technology, Inc., as Chief Executive Officer & Director from 2024.
Ms. Dodd also formerly worked at Johnson & Johnson, as Vice President-Health Economics & Reimbursement from 1997 to 2010, World Health Organization (United States), as Project Manager from 1988 to 1993, Medtronic Plc, as VP & GM-Medtronic Care Management Services from 2018 to 2022, and Medtronic Canada ULC, as President.
Ms. Dodd received her graduate degree from London School of Hygiene & Tropical Medicine, undergraduate degree from The College of Idaho, Inc., and graduate degree from London School of Economics & Political Science.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
TACTILE SYSTEMS TECHNOLOGY, INC. 0.78%	07/08/2025	173,479 ( 0.78% )	5 M $	30/12/2025

Sheri Dodd active positions

Companies	Position	Start
TACTILE SYSTEMS TECHNOLOGY, INC.	Chief Executive Officer	30/06/2024

All active positions of Sheri Dodd

Former positions of Sheri Dodd

Companies	Position	End
MEDTRONIC PLC	Corporate Officer/Principal	31/10/2022
JOHNSON & JOHNSON	Corporate Officer/Principal	28/02/2010
World Health Organization (United States) World Health Organization (United States) The World Health Organization (United States) operates through platforms that focus on women's health advocacy and regulatory updates. The private company is based in Washington, DC. The organization emphasizes FDA safety warnings on long-acting asthma drugs, scientific inquiry into HPV vaccines, and updates on vaccine approvals, including those for the 2009 H1N1 influenza virus. It highlights expanded FDA approvals for Merck’s Gardasil vaccine, extending its use to women up to 45 years old and young men for genital wart prevention. The organization covers a range of health topics such as cancer, HPV, vaccination policies, and drug safety, promoting transparency, safety awareness, and engagement in women's health issues through informative and advocacy-oriented content.	Corporate Officer/Principal	31/08/1993
Medtronic Canada ULC Medtronic Canada ULC Medical SpecialtiesHealth Technology Manufactures medical devices	President	-

See the detail of Sheri Dodd's experience

Training of Sheri Dodd

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sheri Dodd's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Johnson & Johnson Johnson & Johnson Operates as an investment holding company with interests in health care products
Tactile Systems Technology, Inc. Tactile Systems Technology, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices	Health Technology
London School of Hygiene & Tropical Medicine London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
London School of Economics & Political Science London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Medtronic Canada ULC Medtronic Canada ULC Medical SpecialtiesHealth Technology Manufactures medical devices	Health Technology
The College of Idaho, Inc. The College of Idaho, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Medtronic Plc Medtronic Plc Provides medical technology services
World Health Organization (United States) World Health Organization (United States) The World Health Organization (United States) operates through platforms that focus on women's health advocacy and regulatory updates. The private company is based in Washington, DC. The organization emphasizes FDA safety warnings on long-acting asthma drugs, scientific inquiry into HPV vaccines, and updates on vaccine approvals, including those for the 2009 H1N1 influenza virus. It highlights expanded FDA approvals for Merck’s Gardasil vaccine, extending its use to women up to 45 years old and young men for genital wart prevention. The organization covers a range of health topics such as cancer, HPV, vaccination policies, and drug safety, promoting transparency, safety awareness, and engagement in women's health issues through informative and advocacy-oriented content.